While reporting financial results for the fourth quarter on Thursday, Alexion Pharmaceuticals Inc. (ALXN) initiated its earnings and total revenue guidance for the full year 2020, below analysts' expectations.
from RTT - Earnings https://ift.tt/2RF3aeM
via IFTTT
No comments:
Post a Comment